Kastle Theraps Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KASTLE THERAPS LLC, and when can generic versions of KASTLE THERAPS LLC drugs launch?
KASTLE THERAPS LLC has one approved drug.
There is one US patent protecting KASTLE THERAPS LLC drugs.
There are thirty-seven patent family members on KASTLE THERAPS LLC drugs in eleven countries.
Summary for Kastle Theraps Llc
International Patents: | 37 |
US Patents: | 1 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Kastle Theraps Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kastle Theraps Llc | KYNAMRO | mipomersen sodium | SOLUTION;SUBCUTANEOUS | 203568-001 | Jan 29, 2013 | DISCN | Yes | No | 7,511,131 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Kastle Theraps Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Kastle Theraps Llc | KYNAMRO | mipomersen sodium | SOLUTION;SUBCUTANEOUS | 203568-001 | Jan 29, 2013 | 5,914,396 | ⤷ Sign Up |
Kastle Theraps Llc | KYNAMRO | mipomersen sodium | SOLUTION;SUBCUTANEOUS | 203568-001 | Jan 29, 2013 | 6,451,991 | ⤷ Sign Up |
Kastle Theraps Llc | KYNAMRO | mipomersen sodium | SOLUTION;SUBCUTANEOUS | 203568-001 | Jan 29, 2013 | 7,015,315 | ⤷ Sign Up |
Kastle Theraps Llc | KYNAMRO | mipomersen sodium | SOLUTION;SUBCUTANEOUS | 203568-001 | Jan 29, 2013 | 7,407,943 | ⤷ Sign Up |
Kastle Theraps Llc | KYNAMRO | mipomersen sodium | SOLUTION;SUBCUTANEOUS | 203568-001 | Jan 29, 2013 | 7,101,993 | ⤷ Sign Up |
Kastle Theraps Llc | KYNAMRO | mipomersen sodium | SOLUTION;SUBCUTANEOUS | 203568-001 | Jan 29, 2013 | 6,222,025 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Kastle Theraps Llc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 03097662 | ⤷ Sign Up |
European Patent Office | 2336319 | ⤷ Sign Up |
Japan | 2005503142 | ⤷ Sign Up |
Japan | 2015198669 | ⤷ Sign Up |
Japan | 5342493 | ⤷ Sign Up |
Canada | 2505801 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.